Michael Heile, MD
Family Medicine · Cincinnati, OHNPI 1588628234
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $196,904 of the $272,220 with a category attached, or 72.3%. 60 manufacturers reported payments, led by Novo Nordisk at 49.3% of the total. Reporting peaked in 2022 at $53,480 and has fallen 60.0% since, to $21,389 in 2025. Among family medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 950 payments — averaging $286.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$134K
- Dexcom, Inc.$45K
- Abbott$23K
- Insulet Corporation$21K
- Johnson & Johnson$17K
- Roche Diabetes Care GmbH$11K
- plus $20K from 54 others
What the payments were for
- Consulting fees$37,71914%
- Speaking & faculty fees$196,90472%
- Travel & lodging$18,5077%
- Food & beverage$18,9187%
- Education$530%
- Gifts$1190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$50,367
- RYBELSUS$46,735
- DEXCOM G7 GSS (161)$28,142
- Omnipod$20,675
- INVOKANA$16,525
- Tresiba$11,469
- DEXCOM G6 TRANSMITTER$8,124
- FreeStyle Libre 2$7,338
- FreeStyle Libre Pro$6,573
- TZIELD$5,206
- DEXCOM CGM$4,956
- DC ACCU-CHEK Diabetes Management Solutions, Cables, Software, Kits and Accessori$4,927
- DEXCOM STELO GLUCOSE BIOSENSOR$4,498
- Accu-Chek Instruments$3,895
- FARXIGA$3,357
- DEXCOM G6 CGM SYSTEM$3,301
- DC ACCU-CHEK Pump, Kits, Infusion Sets and Accessories$2,464
- FreeStyle Libre$2,146
- FREESTYLE LIBRE 3$1,905
- DISEASE STATE$1,091
How this compares
$272,220 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 153 | $204,623 |
| TrulicityDulaglutide | 76 | $106,856 |
| JardianceEmpagliflozin | 69 | $77,947 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 50 | $64,274 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 50 | $50,985 |
| RybelsusSemaglutide | 30 | $46,088 |
| MounjaroTirzepatide | 31 | $41,244 |
| EliquisApixaban | 50 | $40,354 |
| XareltoRivaroxaban | 31 | $33,543 |
| JanuviaSitagliptin Phosphate | 25 | $29,733 |
| Tresiba Flextouch U-200Insulin Degludec | 25 | $27,911 |
| Repatha SureclickEvolocumab | 30 | $25,263 |
| InvokanaCanagliflozin | 22 | $22,819 |
| FarxigaDapagliflozin Propanediol | 19 | $21,223 |
| TradjentaLinagliptin | 22 | $20,406 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $134,100 | $256,804200 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta | $249 | $162,626141 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $1,093 | $154,273126 claims |
| Johnson & JohnsonXarelto, Invokana | $17,362 | $56,36253 claims |
| PfizerEliquis | $152 | $40,35450 claims |
| MerckJanuvia | $240 | $29,73325 claims |
| AstraZenecaFarxiga | $3,772 | $21,22319 claims |
| AbbVieLinzess, Synthroid | $552 | $9,20447 claims |
| Sanofi-aventis U.S. LLCLantus | $9,545 | $2,56517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Cincinnati
- Amy MechleyCincinnati$120K
- Melissa SchroerCincinnati$116K
- William CoxCincinnati$23K
- Jeffrey SusmanCincinnati$21K
- Ginger KubalaCincinnati$19K
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.